Novo Nordisk Invest 4 A/S

Novo Nordisk Invest 4 A/S is a company in Bagsvaerd, Denmark that has taken part in 9 EU-funded projects since 2010, receiving €3.6M in EU funding and leading 1 as coordinator.

EU funding received€3.6M
EU projects9
As coordinator1
Running now0
First EU project2010
Latest project2016
CountryDenmark
EU registration (PIC)996537649
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Novo Nordisk Invest 4 A/S's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€3.3M · 7 projects
  • Horizon 2020€315k · 2 projects

Projects

9 EU-funded projects, newest first. Novo Nordisk Invest 4 A/S led 1 of them as coordinator. Each links to the official record.

  • GALAXYPartner

    GALAXY: Gut-and-liver axis in alcoholic liver fibrosis

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €130ktheir share
  • EPoSPartner

    Elucidating Pathways of Steatohepatitis

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €184ktheir share
  • METSYPartner

    Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €374ktheir share
  • REDDSTARPartner

    Repair of Diabetic Damage by Stromal Cell Administration

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €459ktheir share
  • COSMOSPartner

    Developing an efficient e-infrastructure, standards and data-flow for metabolomics and its interface to biomedical and life science e-infrastructures in Europe and world-wide

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €50ktheir share
  • DEXLIFECoordinator

    Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €942ktheir share
  • PRIORITYPartner

    Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €880ktheir share
  • BETABATPartner

    Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €210ktheir share
  • SYSKIDPartner

    Systems biology towards novel chronic kidney disease diagnosis and treatment

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €337ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • continuous glucose monitors
  • databases
  • diabetes
  • diabetic nephropathy
  • epidemiology
  • fruit growing
  • genetics
  • hepatology
  • kidney diseases
  • lipids
  • magnetic resonance imaging
  • molecular biology
  • nutrition
  • obesity

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime